Back to results
US 2009/0156621 A1Published application
Hcv inhibitors
OwnerKristian Gudmundssoninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds that are useful in the treatment of viruses belonging to Flaviviridae, including flaviviruses, pestiviruses, and hepaciviruses. The invention includes compounds useful for the treatment or prophylaxis of dengue fever, yellow fever, West Nile virus, and HCV.
Claims30
A method for the treatment or prophylaxis of Flaviviridae viruses through administration of a compound of formula (I):
- wherein
- n is 0, 1, or 2;
- X is NH, O, or S(O)m;
- each R is the same or different and is independently selected from the group consisting
- of halogen, haloalkyl, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, —R10cycloalkyl, Ay, —NHR10Ay, Het, —NHHet, —NHR10Het, —OR2, —OAy, —OHet, —R10OR2, —NR2R3, —NR2Ay, —R10NR2R3, —R10NR2Ay, —R10C(O)R2, —C(O)R2, —CO2R2, —R10CO2R2, —C(O)NR2R3, —C(O)Ay, —C(O)NR2Ay, —C(O)Het, —C(O)NHR10Het, —R10C(O)NR2R3, —C(S)NR2R3, —R10C(S)NR2R3, —R10NHC(NH)NR2R3, —C(NH)NR2R3, —R10C(NH)NR2R3, —S(O)2NR2R3, —S(O)2NR2Ay, —R10SO2NHCOR2, —R10SO2NR2R3, —R10SO2R2, —S(O)mR2, cyano, nitro, or azido;
- each R1 is the same or different and is independently selected from the group consisting of halogen, haloalkyl, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, —R10 cycloalkyl, Ay, —NHR10Ay, Het, —NHHet, —NHR10Het, —OR2, —OAy, —OHet, —R10OR2, —NR2R3, —NR2Ay, —R10NR2R3, —R10NR2Ay, —R10C(O)R2, —C(O)R2,
- —CO2R2, —R10CO2R2, —C(O)NR2R3, —C(O)Ay, —C(O)NR2Ay, —C(O)Het, —C(O)NHR10Het, —R10C(O)NR2R3, —C(S)NR2R3, —R10C(S)NR2R3, —R10NHC(NH)NR2R3, —C(NH)NR2R3, —R10C(NH)NR2R3, —S(O)2NR2R3, —S(O)2NR2Ay, —R10SO2NHCOR2, —R10SO2NR2R3, —R10SO2R2, —S(O)mR2, cyano, nitro, or azido;
- each m independently is 0, 1, or 2;
- each R10 is the same or different and is independently selected from alkylene, cycloalkylene, alkenylene, cycloalkenylene, and alkynylene;
- p and q are each independently selected from 0, 1, 2, 3, 4, or 5;
- each of R2 and R3 are the same or different and are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, —R10cycloalkyl, —R10OH, —R10(OR10)w, and —R10NR4R5;
- w is 1-10;
- each of R4 and R5 are the same or different and are independently selected from the group consisting of alkyl, cycloalkyl, alkenyl, cycloalkenyl, and alkynyl;
- Ay represents an aryl group;
- Het represents a 5- or 6-membered heterocyclyl or heteroaryl group;
- ring A is aryl or heteroaryl;
- and
- pharmaceutically acceptable salts and solvates.
15 more elements
A use of a compound of formula (I):
- wherein:
- n is 0, 1, or 2;
- X is NH, O, or S(O)m;
- each R is the same or different and is independently selected from the group consisting
- of halogen, haloalkyl, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, —R10cycloalkyl, Ay, —NHR10Ay, Het, —NHHet, —NHR10Het, —OR2, —OAy, —OHet, —R10OR2, —NR2R3, —NR2Ay, —R10NR2R3, —R10NR2Ay, —R10C(O)R2, —C(O)R2, —CO2R2, —R10CO2R2, —C(O)NR2R3, —C(O)Ay, —C(O)NR2Ay, —C(O)Het, —C(O)NHR10Het, —R10C(O)NR2R3, —C(S)NR2R3, —R10C(S)NR2R3, —R10NHC(NH)NR2R3, —C(NH)NR2R3, —R10C(NH)NR2R3, —S(O)2NR2R3, —S(O)2NR2Ay, —R10SO2NHCOR2, —R10SO2NR2R3, —R10SO2R2, —S(O)mR2, cyano, nitro, or azido;
- each R1 is the same or different and is independently selected from the group consisting of halogen, haloalkyl, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, —R10 cycloalkyl, Ay, —NHR10Ay, Het, —NHHet, —NHR10Het, —OR2, —OAy, —OHet, —R10OR2, —NR2R3, —NR2Ay, —R10NR2R3, —R10NR2Ay, —R10C(O)R2, —C(O)R2, —CO2R2, —R10CO2R2, —C(O)NR2R3, —C(O)Ay, —C(O)NR2Ay, —C(O)Het, —C(O)NHR10Het, —R10C(O)NR2R3, —C(S)NR2R3, —R10C(S)NR2R3, —R10NHC(NH)NR2R3, —C(NH)NR2R3, —R10C(NH)NR2R3, —S(O)2NR2R3, —S(O)2NR2Ay, —R10SO2NHCOR2, —R10SO2NR2R3, —R10SO2R2, —S(O)mR2, cyano, nitro, or azido;
- each m independently is 0, 1, or 2;
- each R10 is the same or different and is independently selected from alkylene, cycloalkylene, alkenylene, cycloalkenylene, and alkynylene;
- p and q are each independently selected from 0, 1, 2, 3, 4, or 5;
- each of R2 and R3 are the same or different and are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, —R10cycloalkyl, —R10OH, —R10(OR10)w, and —R10NR4R5;
- w is 1-10;
- each of R4 and R5 are the same or different and are independently selected from the group consisting of alkyl, cycloalkyl, alkenyl, cycloalkenyl, and alkynyl;
- Ay represents an aryl group;
- Het represents a 5- or 6-membered heterocyclyl or heteroaryl group;
- ring A is aryl or heteroaryl;
- and
- pharmaceutically acceptable salts and solvates thereof, in the manufacture of a medicament for use in the treatment or prophylaxis of viruses belonging to Flaviviridae.
14 more elements
Dependencies are inferred from the claim text.